(2R,5S,6S)-5-[[(6S,7S,8aR)-7,8-dihydroxy-2-phenyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (2R,5S,6S)-5-[[(6S,7S,8aR)-7,8-dihydroxy-2-phenyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol
• 化学式: C₁₉H₂₆O₁₁
• 分子量: 430.4
• InChiKey: FDSQLLVSEWZNNT-HDCCIOJFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.8
• 重原子数：
  30
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.68
• 拓扑面积：
  168
• 氢给体数：
  6
• 氢受体数：
  11

文献信息

• CARBOHYDRATE-LIPID CONSTRUCTS AND THEIR USE IN PREVENTING OR TREATING VIRAL INFECTION
  申请人：Kode Biotech Limited

  公开号：US20140200191A1

  公开（公告）日：2014-07-17

  The invention relates to selected carbohydrate-lipid constructs and their use as mimics of ligands for receptors expressed by a virus. In particular, the invention relates to the use of selected carbohydrate-lipid constructs in methods of inhibiting virus infection and/or promoting clearance of virus from infected subjects. Carbohydrate-lipid constructs selected for use in these methods where the virus is Human Immunodeficiency Virus (HIV) are provided.
• FUNCTIONAL LIPID CONSTRUCTS
  申请人：KODE BIOTECH LIMITED

  公开号：US20170218027A1

  公开（公告）日：2017-08-03

  The invention relates to functional lipid constructs and their use in diagnostic and therapeutic applications, including serodiagnosis, where the functional moiety is carbohydrate, peptide, chemically reactive group, conjugator or fluorophore.
• US9226968B2
  申请人：——

  公开号：US9226968B2

  公开（公告）日：2016-01-05